New England Journal of Medicine · 1977 · 182 citations · 5 references
MedicineMaternal HealthObstetricsPerinatal EpidemiologyReproductive EndocrinologyReproductive EpidemiologyBirth Defects EpidemiologyPerinatal Risk FactorsPregnancyPregnancy EndocrinologyPrenatal DevelopmentReproductive RiskCardiovascular Complications Of PregnancyCardiovascular Outcomes In OffspringCongenital Anomaly RiskCongenital Cardiovascular MalformationsCongenital Malformation RiskContraceptive HormonesEndocrine HormonesFetal Cardiovascular Malformations
In a cohort of 50,282 pregnancies 19 children with cardiovascular defects were born to 1042 women who received female hormones during early pregnancy (18.2 per 1000). Among 49,240 children not exposed in utero to these agents there were 385 with cardiovascular malformations (7.8 per 1000). Six children with cardiovascular defects were born to a sub-group of 278 women who used oral contraceptives during early pregnancy (21.5 per 1000). After the data were controlled for a wide variety of potentially confounding factors by multivariate methods, the association between in utero exposure to female hormones and cardiovascular birth defects was statistically significant.
5
BIRTH DEFECTS AND ORAL CONTRACEPTIVES
JamesJ. Nora, AudreyH. Nora · The Lancet · 1973 · 156 citations
HORMONE TREATMENT DURING PREGNANCY AND CONGENITAL HEART DEFECTS
EdithP. Levy, Avrahm Cohen, F. Clarke Fraser · The Lancet · 1973 · 114 citations
Medicine, Cardiology, Endocrinology +10
BIRTH DEFECTS AND ŒSTROGENS AND PROGESTERONES IN PREGNANCY
Susan Harlap, R Prywes, A.M. Davies · The Lancet · 1975 · 81 citations
Medicine, Endocrinology, Obstetrics +10
CONGENITAL ABNORMALITIES AND FIRST-TRIMESTER EXPOSURE TO PROGESTAGEN/ŒSTROGEN
JamesJ. Nora, AudreyH. Nora, AnnG. Perinchief et al. · The Lancet · 1976 · 55 citations
Medicine, Endocrinology, Obstetrics +10